Pathway Headlines

Cardiovascular Business

Pathway Labs receives FDA clearance for EchoNext and raises $8.5M in seed funding.

Companies:Pathway

Worldnews.com

Aggregated article on Pathway Labs' FDA clearance and partnership.

Companies:Pathway

Rutland Herald

Republish of Business Wire article on Pathway Labs' FDA clearance and partnership.

Companies:Pathway

BriefGlance.com

Investment analysis of Pathway Labs' FDA clearance and market potential.

Companies:Pathway

Streamline

EchoNext AI integrated with OpenEvidence for heart disease detection.

Companies:Pathway

Morningstar

Republish of Business Wire article on Pathway Labs' FDA clearance and partnership.

Companies:Pathway

Business Wire

Pathway Labs announces FDA clearance for its EchoNext AI, partnership with OpenEvidence, and an $8.5M seed round.

Companies:Pathway

STARTUP IN EUROPE

Pathway, a deeptech startup specializing in real-time data processing, has raised €9.4M ($10M) in seed funding to expand its commercial presence in the U.S. and further develop its 'live AI' technology.

Companies:Pathway

Computer Weekly

Pathway, a post-transformer AI lab, claims to be delivering a faster path to AGI through true continuous learning and long-horizon reasoning with its BDH architecture, which gives LLMs native reasoning powers and intrinsic memory mechanisms. The article highlights how Pathway's model excels at Sudoku puzzles, addressing a major gap in LLM capability.

Companies:Pathway

Pathway Blog

Pathway announced that its new model, BDH, has achieved 97.4% accuracy in solving Sudoku Extreme puzzles, a task where leading LLMs have struggled.

Companies:Pathway